First ever disease-modifying drug for osteoarthritis

被引：0
|
作者：
Fricker, Janet
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 04期
关键词：
D O I：
10.12968/hmed.2012.73.4.188
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [41] RAPAMYCIN, A POTENTIAL DISEASE-MODIFYING ANTIARTHRITIC DRUG
    CARLSON, RP
    HARTMAN, DA
    TOMCHEK, LA
    WALTER, TL
    LUGAY, JR
    CALHOUN, W
    SEHGAL, SN
    CHANG, JY
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 266 (02): : 1125 - 1138
  • [42] Predicting knee replacement in participants eligible for disease-modifying osteoarthritis drug treatment with structural endpoints
    Kwoh, C. K.
    Guehring, H.
    Aydemir, A.
    Hannon, M. J.
    Eckstein, F.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 (06) : 782 - 791
  • [43] Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug
    Mazzuca, SA
    Brandt, KD
    Katz, BP
    Lane, KA
    Bradley, JD
    Heck, LW
    Hugenberg, ST
    Manzi, S
    Moreland, LW
    Oddis, CV
    Schnitzer, TJ
    Sharma, L
    Wolfe, F
    Yocum, DE
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (06): : 933 - 940
  • [44] IGURATIMOD: A NEW DISEASE-MODIFYING ANTIRHEUMATIC DRUG
    Mucke, H. A. M.
    DRUGS OF TODAY, 2012, 48 (09) : 577 - 586
  • [45] Disease-modifying drug therapy in cystic fibrosis
    Harman, Katharine
    Dobra, Rebecca
    Davies, Jane C.
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 26 : 7 - 9
  • [46] Disease-modifying potential of diphenyl diselenide in an experimental osteoarthritis model
    Qiao, Li
    Li, Zhiyao
    Shi, Peihua
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 710
  • [47] Diacerein has a structure/disease-modifying effect on hip osteoarthritis
    Provvedini, DM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (06) : 788 - 788
  • [48] Lead optimization of cathepsin K inhibitors for disease-modifying osteoarthritis
    Ginnetti, Anthony
    Paone, Daniel
    Nanda, Kausik
    Green, Ahren
    Burgey, Christopher
    Duong, Le
    Glantschnig, Helmut
    Huang, Lingyi
    Lu, Ping
    McElwee-Witmer, Shelia
    Vogel, Robert
    Wei, Nan
    Wesolowski, Gregg
    Carroll, Steve
    Mosser, Scott
    Robinson, Ron
    Adamski, Sharon
    Eular, Danielle
    Hatcher, Nate
    Luo, Bin
    Lubbers, Laura
    Webber, Hans
    Wessner, Keith
    Anderson, Ken
    Crathern, Susan
    Dooney, Deborah
    Ellis, Joan
    Kuo, Yushi
    Ma, Bennett
    Rudd, Deanne
    Wan, Bang-Lin
    Wudarski, Christen
    Zrada, Matthew
    Stachel, Shawn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [49] The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date
    Oo, Win Min
    Little, Christopher
    Duong, Vicky
    Hunter, David J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2921 - 2945
  • [50] Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity
    Goldberg, VM
    Buckwalter, JA
    OSTEOARTHRITIS AND CARTILAGE, 2005, 13 (03) : 216 - 224
12345